We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Race Prescription Card.
- Authors
Davies, Kevin
- Abstract
Presents information on a heart disease drug BiDil that is particularly effective in African Americans. Information on A-HeFT, a Phase III trial of of several African American patients, launched by Lexington, Massachusetts-based NitroMed with the support from the Association of Black Cardiologists and the Congressional Black Caucus; Comments from David Goldstein of University College London on the drug; Statement given by Francis Collins, director of the National Human Genome Research Institute, on the impact of the wide-ranging frequencies of gene markers across different populations.
- Subjects
DRUGS; HEART diseases; AFRICAN Americans; CLINICAL trials; NITROMED Inc.; PATIENTS; AFRICAN American membership in associations, institutions, etc.; CARDIOLOGISTS; GOLDSTEIN, David; UNIVERSITY College, London; COLLINS, Francis S., 1950-; CORPORATE directors; HUMAN genome; RESEARCH institutes; HUMAN population genetics
- Publication
Bio-IT World, 2005, Vol 4, Issue 1, p4
- ISSN
1538-5728
- Publication type
Article